NCT06920056 - A Study of BGM0504 in Overweight or Obese Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

July 25, 2025

Study Completion Date

July 25, 2025

Conditions

Overweight or Obese

Interventions

DRUG

Paracetamol

oral, postprandial

DRUG

Metformin Hydrochloride

Oral , Fasting

DRUG

Warfarin

Oral , Fasting

DRUG

BGM0504

Administered SC

Trial Locations (1)

650100

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine), Kunming

All Listed Sponsors

lead

BrightGene Bio-Medical Technology Co., Ltd.

INDUSTRY